Presenilins are Required for Maintenance of Neural Stem Cells in the Developing Brain by Kim, Woo-Young & Shen, Jie
 
Presenilins are Required for Maintenance of Neural Stem Cells in
the Developing Brain
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Kim, Woo-Young, and Jie Shen. 2008. Presenilins are required for
maintenance of neural stem cells in the developing brain.
Molecular Neurodegeneration 3: 2.
Published Version doi://10.1186/1750-1326-3-2
Accessed February 19, 2015 7:41:38 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4737683
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAABioMed  Central
Page 1 of 13
(page number not for citation purposes)
Molecular Neurodegeneration
Open Access Research article
Presenilins are required for maintenance of neural stem cells in the 
developing brain
Woo-Young Kim1,2 and Jie Shen*1
Address: 1Center for Neurologic Diseases, Brigham & Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, 
USA and 2Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, 
USA
Email: Woo-Young Kim - wkim@mdanderson.org; Jie Shen* - jshen@rics.bwh.harvard.edu
* Corresponding author    
Abstract
The early embryonic lethality of mutant mice bearing germ-line deletions of both presenilin genes
precluded the study of their functions in neural development. We therefore employed the Cre-
loxP technology to generate presenilin conditional double knockout (PS cDKO) mice, in which
expression of both presenilins is inactivated in neural progenitor cells (NPC) or neural stem cells
and their derivative neurons and glia beginning at embryonic day 11 (E11). In PS cDKO mice,
dividing NPCs labeled by BrdU are decreased in number beginning at E13.5. By E15.5, fewer than
20% of NPCs remain in PS  cDKO mice. The depletion of NPCs is accompanied by severe
morphological defects and hemorrhages in the PS cDKO embryonic brain. Interkinetic nuclear
migration of NPCs is also disrupted in PS cDKO embryos, as evidenced by displacement of S-phase
and M-phase nuclei in the ventricular zone of the telencephalon. Furthermore, the depletion of
neural progenitor cells in PS cDKO embryos is due to NPCs exiting cell cycle and differentiating
into neurons rather than reentering cell cycle between E13.5 and E14.5 following PS inactivation in
most NPCs. The length of cell cycle, however, is unchanged in PS cDKO embryos. Expression of
Notch target genes, Hes1 and Hes5, is significantly decreased in PS cDKO brains, whereas Dll1
expression is up-regulated, indicating that Notch signaling is effectively blocked by PS inactivation.
These findings demonstrate that presenilins are essential for neural progenitor cells to re-enter cell
cycle and thus ensure proper expansion of neural progenitor pool during embryonic neural
development.
Background
During mammalian neural development, neural progeni-
tor cells (NPCs) divide and populate the progenitor pool
in the ventricular zone (VZ) of the developing telen-
cephalon [1]. There are two phases of neurogenesis. The
first phase spans from embryonic day 8.5 (E8.5) to 10.5,
during which neural progenitor population expands. The
second phase commences around E11.5, reaches peak by
E15.5, and then diminishes by E17.5, generating most of
the cortical neurons through eleven cell cycles [2-6]. Dur-
ing the first phase, neural progenitor cells are columnar,
connecting the pial surface and the apical surface, and pre-
dominantly undergo symmetric cell division to expand
rapidly the self-renewal founder progenitor cells [6,7].
During the second phase, neural progenitors in the ven-
tricular zone predominantly undergo asymmetric cell
division to generate self-renewal daughter progenitor cells
that remain in the cell cycle and committed postmitotic
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neural precursor daughter cells that will ultimately differ-
entiate into neurons or glia [3,7-10]. Notch receptors are
required for neural progenitor cell proliferation [11-13].
In the cell cycle of this asymmetric cell division, at the
transition from S phase to M phase, the dividing neural
progenitor cells displace their nuclei and subsequently
migrate from the basal membrane to the apical surface of
the neuroepithelium, a phenomenon termed interkinetic
nuclear migration (INM) [14,15].
Presenilin-1  (PS1) and presenilin-2  (PS2) are the major
causative genes of familiar Alzheimer disease (FAD) [16].
Presenilin (PS) is an essential component of the γ-secre-
tase complex, and Notch is one of the physiological sub-
strates of γ-secretase [17]. Notch is one of the most
important regulators of neural development in organisms
from insects to mammals [18-20]. During mammalian
neural development, activation of the Notch signaling
pathway is involved in the maintenance of neural progen-
itor identity and the decision of cell fate [21]. Presenilin is
required for Notch signaling during neural development,
though expression of Hes1, one of the Notch downstream
effector genes, is not suppressed by inactivation of PS1,
whereas expression of Hes5 is effectively suppressed [22].
The germ-line deletion of PS1 in mice results in perinatal
lethality, cerebral hemorrhages and impairment of neuro-
genesis, likely due to down-regulation of Notch signaling
[22,23]. Although no phenotypes have been observed in
PS2-null mice [24], earlier and more severe developmen-
tal defects are found in PS1/PS2 double knockout mice
than in PS1 single knockout mice [25]. This finding sug-
gests functional redundancy between PS1 and PS2 in
embryonic development. When PS1  inactivation is
restricted to NPC and NPC-derived neurons and glia
beginning at ~E11 during the second phase of neurogen-
esis, the NPC-PS1 cKO mice can live up to 2–3 months
postnatally. These mice harbor defects in neuronal migra-
tion, cortical lamination and radial glial development
with milder loss of the progenitor cells [26].
Here we investigate that role of both presenilins in neural
development, especially in the maintenance of neural
progenitor or stem cell population. We employed a Nes-
tin-Cre  transgene to circumvent the early embryonic
lethality associated with the germ-line deletion of both
PS1 and PS2 loci and to restrict PS inactivation to NPCs
and NPC-derived neurons and glia. Using this conditional
double knockout mouse model, we found that presenilins
are required for neural progenitor cells to re-enter cell
cycle and for the expansion of neural progenitor popula-
tion during embryonic development. Precocious exit of
cell cycle observed in PS cDKO mice is accompanied by
disruption of interkinetic nuclear migration and is fol-
lowed by premature differentiation into postmitotic neu-
rons. Blockade of expression of Notch downstream target
genes, Hes1 and Hes5, in PS cDKO mice may underlie or
contribute to the failure of neural progenitor cells to re-
enter cell cycle. Thus, presenilins play an essential role for
NPCs or neural stem cells to retain their self-renewal
capacity to expand the progenitor population.
Results
Gradual loss of PS1 transcripts in the developing PS cDKO 
brain
To determine the spatial and temporal course of PS1 inac-
tivation, we performed in situ hybridization analysis on
the neural progenitor cell (NPC)-restricted PS cDKO mice,
which were generated by crossing floxed PS1 mice with
the Nestin-Cre transgenic mice in the PS2-/- background.
We compared the PS1  mRNA expression in PS  cDKO
(fPS1/fPS1; Nestin-Cre; PS2-/-) embryos and littermate
controls (PS2-/-) using a probe specific for PS1 exons 2
and 3. Consistent with our previous report on the analysis
of spatial and temporal inactivation of PS1 in NPC-PS1
cKO mice [26], we found a marked reduction of PS1
mRNAs in PS cDKO embryos at E11.5. At E12.5, no signif-
icant signal of PS1 mRNAs was detected in the developing
telencephalon of PS cDKO embryos. By E13.5, the PS1
mRNA was no longer detectable throughout the brain
(data not shown).
Severe reduction of neural progenitor cells in PS cDKO 
mice
The NPC-restricted PS cDKO mice die perinatally. After
E15.5, the developing PS cDKO brain appeared smaller
and grossly abnormal compared with brains from litter-
mate PS2-/-mice, in which no abnormal brain phenotype
has been reported [27]. At postnatal day 0 (P0), the PS
cDKO brain is much smaller with lower neuronal density
and disorganized cortical layers. To assess whether the
number of neural progenitor cells in PS cDKO brains was
affected, we performed BrdU pulse labeling on compara-
ble brain sections from PS  cDKO and control mice
between E12.5 and E17.5. BrdU is an analogue of thymi-
dine, thus labels newly synthesized DNA. In the control
brain, BrdU-positive cells in S-phase reside in the deeper
layers of the ventricular zone at these developmental
stages [4]. At E13.5 the BrdU staining pattern was not
noticeably different between control and PS cDKO mice
(Figure 1A, B). By E14.5, PS  cDKO brains exhibit dis-
rupted BrdU staining pattern in many areas and the lateral
ventricle was smaller (Figure 1C, D). At E17.5 the lateral
ventricle became hardly visible in the PS  cDKO brain
(asterisks in Figure 1E, F), and only a few BrdU-positive
progenitor cells remain in the ganglionic eminence (GE)
of the mutant cortex (black arrowheads in Figure 1E, F).
Severe hemorrhages were also observed in all of the PS
cDKO brains after E15.5. Many blood-originated, non
neuronal staining were found in the mutant brain (open
arrowheads in Figure 1F, compare the insets in Figure 1E,Molecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
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Depletion of neural progenitor cells in the PS cDKO embryonic brain Figure 1
Depletion of neural progenitor cells in the PS cDKO embryonic brain. (A-F) Proliferating (S-pahse) neural progeni-
tors are identified by BrdU labeling at E13.5, E14.5 and E17.5. While the BrdU staining pattern does not differ between PS 
cDKO and control embryonic brains at E13.5 (A, B), severe morphological abnormalities of BrdU stained progenitor cells are 
present in PS cDKO brains at E14.5 (C, D). By E17.5, only a few proliferating neural progenitor cells remain in the lateral gan-
glionic eminence (GE, black arrowheads), whereas in the ventricular zone of the telencephalon neural progenitor cells are 
almost completely depleted in the PS cDKO mice brain. Many non-neuronal, unnucleated, clotted and small staining are found 
in the PS cDKO brain (opened arrow heads and inset in F). The lateral ventricle (labeled with an asterisk in the control brain) 
is missing in PS cDKO brains (E, F). The insets in E, F are the high power view of boxed area. Scale bar: 500 µm. (G) Quantifi-
cation of BrdU-labeled S-phase cells. BrdU-positive cells were counted at E12.5, E13.5, E14.5, and E15.5, and the percentage of 
BrdU-positive cells in PS cDKO embryos to that in the control is shown. Significant reductions of BrdU-positive cells are 
detected at E14.5 and E15.5 in PS cDKO mice (**, p < 0.01; ***, p < 0.001).Molecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
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F). The number of BrdU-positive progenitor cells in the
telencephalon of PS  cDKO mice was normal at E12.5
(99.3 ± 6.2%) and slightly reduced at E13.5 (89.5 ± 4.8%;
Figure 1G). By E14.5 and E15.5, the number of BrdU-pos-
itive progenitor cells was further decreased in the PS
cDKO brains (E14.5: 35.2 ± 7.9%, p < 0.01; E15.5: 17.2 ±
2.5%, p < 0.001; Figure 1G). The results demonstrate that
inactivation of presenilins causes drastic reduction of
dividing neuroprogenitor cells after E13.5.
Disrupted interkinetic nuclear migration of neural 
progenitor cells in PS cDKO mice
During the cell cycle neural progenitor cells in the devel-
oping forebrain undergo a process termed interkinetic
nuclear migration (INM) [28]. We then examined
whether inactivation of presenilins affects the INM proc-
ess. At E12.5 and earlier stages, no difference was observed
between PS cDKO and control brains. By E13.5, however,
the S-phase nuclei in the mutant mice were detected in
abnormal positions; rather than localized in the basal are
of the ventricular zone, they are randomly distributed in
the ventricular zone and are especially clustered near the
ventricle (Figure 2A, B). To quantify the ectopic distribu-
tion of the S-phase nuclei, we divided the cortical ven-
tricular zone into 11 bins from the preplate to the
ventricle and then counted the number of the S-phase
nuclei in each bin (Figure 2E). The quantitative analysis
further confirmed the ectopic localization of the S-phase
nuclei at this developmental stage. By E14.5, the interki-
netic nuclear migration was further disrupted in PS cDKO
brains with the S-phase nuclei clustered near the ventricle
surface in many places (Figure 2C, D).
We further performed additional immunostaining to
determine the localization of the progenitor cell nuclei in
M-phase of the cell cycle using phospho-histone 3 (p-his-
tone 3) as a marker. At E13.5, in the control embryo cor-
tex, the p-histone 3-positive nuclei were largely restricted
to the ventricular surface (VS), as expected. However, the
number of p-histone 3-positive nuclei localized at the
basal are of ventricular zone (non-ventricular M-phase
nuclei) was significantly higher in PS cDKO mice (Figure
3A, B and 3I, 24.0 ± 2.1% for control and 49.4 ± 3.6% for
PS cDKO, p < 0.001). However, the total number of M-
phase cells was unchanged at this time (39.7 ± 4.2 for con-
trol, 37.8 ± 3.1 for PS cDKO), similarly to S-phase cells we
observed (Figure 1). The Tuj-1 staining showed a broader
staining pattern in PS cDKO mice, indicative of excessive
neuronal differentiation (Figure 3C and 3D). In PS cDKO
mice, the p-histone 3-positive nuclei were found in the
Tuj-1-positive zone, suggesting precocious differentiation
of the progenitor cells to neurons and the disruption of
the boundary between the ventricular zone and the pre-
plate. This genotypic difference became more profound in
embryos at E14.5, when much fewer p-histone 3-positive
nuclei were present in PS cDKO (17.3 ± 2.7) embryos
than in the control (44.2 ± 7.9, p < 0.5). Furthermore, a
higher percentage of the p-histone 3-positive nuclei were
localized at the basal are of ventricular zone in PS cDKO
mice (61.6 ± 4.9%), compared to the control (20.1 ±
2.4%, p < 0.001; Figure 3E, F, and 3J). The Tuj-1-positive
cells cover most of the ventricular zone at this stage in PS
cDKO mice (Figure 3G and 3H). These results demon-
strate the disruption of interkinetic nuclear migration of
neural progenitor cells in PS cDKO mice.
Premature exit of the cell cycle in neural progenitor cells 
of PS cDKO mice
To determine whether the decrease in the progenitor cells
and the disruption of INM result from the progenitors
exiting the cell cycle to differentiate rather than re-enter-
ing the cell cycle, we examined the cell cycle exit and re-
entry by calculating the fraction of the cells remaining in
the cell cycle during the 24-hour time span. BrdU was
used to label dividing progenitor cells at the time of injec-
tion, and Ki67 immunoreactivity was used to mark cells
that remain in the cell cycle 24 hours later. Thus, dividing
cells labeled by BrdU that have left the cell cycle are
BrdU+/Ki67- (green), whereas dividing cells that remain
in the cell cycle are BrdU+/Ki67+ (yellow in Figure 4A–H).
At E13.5, the percentage of the progenitor cells remaining
in the cell cycle 24 hours after the BrdU injection at E12.5
is lower in PS cDKO mice (40.2% ± 1.6%), compared to
that in the control (56.2% ± 1.9%, p < 0.01; Figure 4I). At
E14.5, the percentage of the cells remaining in the cell
cycle 24 hours after BrdU injection is further decreased in
PS  cDKO mice (9.8% ± 0.5%), relative to the control
(28.4% ± 5.1%, p < 0.05) (Figure 4J). Therefore, in the
absence of PS, most progenitor cells exit the cell cycle and
differentiate into neurons rather than remain as dividing
progenitor cells, resulting in depletion of progenitor cells
in PS cDKO mice.
The result that greater proportion of progenitor cells at
E13.5 and E14.5 fail to reenter cell cycle and differentiate
into postmitotic neurons in PS cDKO mice prompted us
to examine whether the length of the cell cycle in the
mutant is changed, as the longer cell cycle could compli-
cate the interpretation of the results. We investigated the
cell cycle kinetics of the embryos at E13.5, when the neu-
ral progenitor cell number is not changed significantly in
PS cDKO mice. Pregnant mice were given repeated injec-
tions of BrdU to label cumulatively the proliferating pop-
ulation. The proportions of BrdU-labeled cells in the
proliferating zone after different lengths of exposure to
BrdU were plotted in Figure 5A. Using the model
described by Nowakowski et al. [29] and used by others
[4,5,14], these data can be interpreted as summarized in
Figure 5B to give the proportion of cells in the proliferate
zone that are actually proliferating (i.e. the growth frac-Molecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
Page 5 of 13
(page number not for citation purposes)
Ectopic localization of S-phase nuclei in the ventricular zone of PS cDKO brains Figure 2
Ectopic localization of S-phase nuclei in the ventricular zone of PS cDKO brains. (A, B) At E13.5, in control brains, 
the BrdU-positive nuclei are localized in the upper ventricular zone closer to the preplate, whereas in PS cDKO brains, they 
are distributed more broadly and predominantly in the lower ventricular zone closer to the ventricle, suggesting disrupted 
interkinetic nuclear migration. (C, D) At E14.5, in PS cDKO brains, the BrdU-positive nuclei are absent in many areas of the 
ventricular zone and are distributed close to the lateral ventricle. (E) The ventricular zone that contains BrdU-positive cells is 
divided by 11 bins (15 µm/bin). Bin 1 is the layer closest to the preplate (PP), whereas bin 11 is the layer closest to the lateral 
ventricle (LV). n = 5 for the controls and n = 6 for PS cDKO embryos. Scale bar: 100 µm in all figures.
E13.5
E14.5
Control PS cDKO
1
2
3
4
5
6
7
8
9
10
11
CD
1
2
3
4
5
6
7
8
9
10
11
VZ
0
5
10
15
20
25
30
35
40
45
1 2 3 4 5 6 7 8 9 10 11
PS cDKO
Control
bin
S
-
p
h
a
s
e
o
f
 
N
u
c
l
e
i
PP LV
E 13.5
E
B AMolecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
Page 6 of 13
(page number not for citation purposes)
Displacement of M-phase nuclei in the ventricular zone of PS cDKO brains Figure 3
Displacement of M-phase nuclei in the ventricular zone of PS cDKO brains. (A-H) Phospho-histone 3 (p-histone 3, 
red) is used as a marker for cells in M-phase (A, B, E, F), whereas Tuj-1 (green) is used as an early neuronal marker (C, D, G, 
H). While the majority of the M-phase nuclei are found in the ventricular surface (closed arrowheads) of the control brain, 
many M-phase nuclei are found in basal are of the ventricular zone (opened arrowheads) in the developing cortical plate of PS 
cDKO brains at both E13.5 and E14.5, where strong Tuj-1-positive neuronal staining is observed. At E 14.5, most parts of the 
cortex are stained by Tuj-1 already in the mutant while clear layers are observed in the control. The pan early neuronal marker 
stained most area of the PS cDKO brain and only a very small part of the VZ are still left unstained (white star), suggesting that 
most of the neural progenitor cells are already being differentiated in the PS cDKO brain. The arrows indicate the meningeal 
cells. Scale bar: 100 µm. (I, J) Number and the location of p-histone 3 staining in the parasagital section of forebrain (750 µm 
width). At E13.5, in the sections the staining number is not different between the genotype. 76.0% ± 2.1% (SEM) of M-phase 
nuclei are detected in the VS (ventricular M phase nuclei) and about 24.0% of the M-phase nuclei were found in basal are of 
ventricular zone (non-ventricular M phase nuclei) in the control brain. 49.4% ± 3.6% of the M-phase staining in the PS cDKO 
brain are observed in the non-ventricular region, suggesting that the interkinetic nuclear migration is disrupted in the PS cDKO 
embryonic brain. n = 4 for each genotype (I). At E14.5, the p-histone 3 staining is much less in the PS cDKO embryos than con-
trol (p < 0.05). 20.1% ± 2.4% of the M-phase nuclei are detected in non ventricular position in the control, whereas 61.6% ± 
4.9% of those are in non ventricular position in the PS cDKO ; n = 6 and 4 for the wild and mutant embryos respectively (J). 
(***, p < 0.001).
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Reduced percentage of neural progenitor cells reentering the cell cycle in PS cDKO embryos Figure 4
Reduced percentage of neural progenitor cells reentering the cell cycle in PS cDKO embryos. Immunofluorescent 
staining of BrdU (green) and the proliferating cell marker Ki67 (red, staining all cell cycle stages except G0). (A-D) E13.5 
embryos labeled by BrdU at E12.5. (E-H) E14.5 embryos labeled by BrdU at E13.5. (I, J) The proportions of cells which reen-
tered cell cycle are shown as (%). Much less portion of the neural progenitor cells reentered the cell cycle in the PS cDKO 
embryonic brain (*, p < 0.05). Scale bar: 100 µm.
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tion, GF), the length of the cell cycle (Tc) and the length
of S phase (Ts). Previously it was reported that the length
of the entire cell cycle and the length of S-phase are longer
in PS1-deficient neural precursor cells than in wild-type
controls at E14.5 [30]. However, we found that Tc (10.5)
and Ts (5.3) in PS cDKO mice were very similar to those
of control embryos (11.0 and 5.2, respectively). The Tc
and Ts values we obtained in control mice were similar to
those reported previously at this age [31]. Therefore we
conclude that the cell cycle kinetics was not changed in PS
cDKO neural progenitor cells.
Suppression of Notch signaling in the PS cDKO embryonic 
brain
We further investigated how Notch signaling is affected in
the absence of presenilins. In situ hybridization analysis
showed that expression of one of the Notch ligands, Dll1,
was increased in PS cDKO mice (Figure 6A, B), similarly
as what was observed in PS1-null mice [22]. Furthermore,
expression of both Hes1 and Hes5 was decreased in the PS
cDKO embryonic brain (Figure 6C–F). To quantify the
differences, we also performed quantitative real-time RT-
PCR (Figure 6G). The result showed levels of Dll1 (140.1
± 17.5%, p < 0.05), Hes1 (60.6 ± 16.8%, p < 0.01), and
Hes5 (58.5 ± 9.7%, p < 0.05) transcripts were changed in
the  PS  cDKO cortex at E13.5, relative to the control
(100%). Thus, Notch signaling in the developing embry-
onic brain is more effectively suppressed by inactivation
of both PS1 and PS2 in neural progenitor cells than in
PS1-null mice [22]. The unchanged expression of Hes1 in
PS1-null mice is likely due to the normal expression of
PS2, which may compensate for the absence of PS1 on the
expression of Hes1 during neural development.
Discussion
The role of presenilins in the second wave of neurogenesis
was not studied previously. The regulation of the interki-
netic nuclear migration and asymmetric cell division of
the neural progenitor cells in the neocortical development
was unclear. Here we demonstrate that neural progenitor
cells lacking both presenilins fail to maintain their stem
cell identity and self-renewal capacity, resulting in deple-
tion of the progenitor population. The interkinetic
nuclear migration of neural progenitor cells is also dis-
rupted in the absence of presenilins and is accompanied
by the failure of reentering the cell cycle, which leads to
precocious neuronal differentiation. Notch signaling was
effectively suppressed by inactivation of both presenilins.
Together, these findings have uncovered a critical role of
presenilins in the cell cycle regulation of neural progenitor
cells and the proper expansion of the progenitor popula-
tion.
Presenilins in the maintenance of neural progenitor cells 
through the cell cycle regulation
Germ-line deletion of the PS1 gene results in precocious
neuronal differentiation and the loss of the neural pro-
genitor cells as early as E10.5 [22]. Conditional inactiva-
tion of PS1 in neural progenitor cells of NPC-PS1 cKO
mice resulted in milder depletion of the progenitor cells,
perhaps due to the later onset of PS1 inactivation in PS1
cKO mice compared to PS1-/- mice [26]. In the current
study, we circumvented the early embryonic lethality
(~E9) exhibited by PS1/PS2-/- mice and restricted inacti-
Unchanged cell cycle kinetics in the PS cDKO embryonic  brain Figure 5
Unchanged cell cycle kinetics in the PS cDKO embry-
onic brain. (A) Graphs show results of cumulative labeling 
with BrdU at E13.5 in PS cDKO (blue dotted line) and con-
trol embryos (black line). Least squares fit analysis of these 
rising phases (excluding data after giving 8.5 h of BrdU to 
embryos of both genotypes) yielded the trendlines and R2 
values shown. Data points are means ± SEM of the propor-
tions of BrdU-labeled cells, labeling index (LI), in the cortex 
of each embryo. (B) The growth fraction (GF), the length of 
S phase (Ts) and the length of the cell cycle (Tc) are calcu-
lated using the following equations. The intercept on the y-
axis, Yi = GF (Ts/Tc); the time where the GF is maximal (Tm) 
= Tc-Ts ; the rate of increase (i.e. the slope) of the propor-
tion of labeled cells = GF/Tc.
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Suppressed Notch signal in the PS cDKO embryonic brain Figure 6
Suppressed Notch signal in the PS cDKO embryonic brain. The expressions of a notch ligand Dll1 and two notch 
downstream target genes, Hes1 and Hes5, were examined by in situ hybridization (A-F) and quantitative RT-PCR (G). The 
comparable E13.5 sections from the control and the PS cDKO brain were used. In all parts of the brain, the changes in the 
expression pattern were similar; the images in the lateral telencephalon are shown. (A, B) The Dll1 expression was increased in 
the PS cDKO. (C, D) Hes1 was expressed weakly in the control but decreased in the PS cDKO. (E, F) The Hes5 expression was 
strong in the control but decreased in the PS cDKO. (G) The expressions of the three genes were examined using real-time 
quantitative RT-PCR. n = 5 for each genotype. All RT-PCR results were concordant with the in situ hybridization results (*, p < 
0.05; **, p < 0.01). Scale bar: 100 µm.
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vation of both PS1 and PS2 to NPCs and NPC-derived
cells. Neural progenitor cells in NPC-PS cDKO mice are
depleted quickly between E12.5 and E15.5, a duration of
about 6.5 cell cycles (the length of the total cell cycle at
E13 is about 11 hours, see Figure 5), to only 17.2% of the
control (Figure 1G).
Despite the fact that interkinetic nuclear migration has
been a hallmark of vertebrate neural progenitors for seven
decades [32], the mechanism underlying INM is not well
understood. Currently, little is known about the molecu-
lar mechanisms controlling this unique mode of nuclear
movement. Here we found that presenilins are required
for the regulation of interkinetic nuclear migration (Fig-
ures 2 and 3). It was already severely disrupted in PS
cDKO mice at E13.5, when the total number of neural
progenitor cells was not yet altered. The abnormal loca-
tion of M- and S-phase nuclei was also accompanied by
the failure of neural progenitor cells reentering the cell
cycle and the precocious neuronal differentiation (Figures
3 and 4). Therefore, we conclude that presenilins are
required for the control of the INM and for the mainte-
nance of daughter cells in the cell cycle, and that the fail-
ure of these processes leads to the depletion of self-
renewable progenitor cell population.
Mechanisms of the cell cycle regulation by presenilins
Presenilin may regulate the cell cycle through its downreg-
ulation of β-catenin in a γ-secretase-independent manner,
as previously reported [33,34]. The transgenic overexpres-
sion of β-catenin in neural progenitor cells promoted
these cells to reenter cell cycle, leading to the expansion of
NPC population and the enlargement of the developing
brain [35]. If presenilins negatively regulate β-catenin in
the developing brain, the elimination of PS in this study
may be expected to activate the Wnt signaling by releasing
free β-catenin, a scenario similar to the transgenic overex-
pression of β-catenin in the brain [35]. However, NPCs
lacking PS exit the cell cycle rather than reenter the cell
cycle, resulting in depletion of progenitor cells. In addi-
tion, we saw no spinal cord abnormality in our NPC-PS
cDKO mice (WYK and JS, unpublished data), whereas a
previous report found elevated nuclear β-catenin in PS1-
null mice and enhanced cell division in the spinal cord
[34]. Therefore, at least for the developmental stages we
have studied, the cell cycle dysregulation in the PS cDKO
mice is unlikely through β-catenin.
A large number of substrates for presenilin-mediated γ-
secretase activity have been reported [36]. Loss of the
enzymatic activity may contribute the dysregulation of
cell cycle in the PS cDKO mice Notch is one of the physi-
ological substrates of γ-secretase and is required for the
proliferation and survival of NPCs or neural stem cells
[11,13,37,38]. The severe depletion of neural progenitor
cells in NPC-PS cDKO mice in the current study is consist-
ent with the notion that Notch signaling is important for
maintaining the NPC population. Hes5  expression is
reduced in Notch1-null mutants and PS1-null mice,
whereas Hes1 expression is not affected in these mutant
mice [12,13,22]. Nevertheless, Hes1 is a primary Notch/
CBF1 target [39,40] and promotes the cell cycle by sup-
pressing p27Kip, a CDK inhibitor [41]. Expression of both
Hes1 and Hes5 is significantly decreased in PS cDKO mice,
suggesting that the presence of either PS1 or PS2 is suffi-
cient for Hes1 expression. When Hes1 and Hes5 were both
mutated, complete loss of neural stem cells was observed
[42]. This suggests that the more efficient blocking of Hes1
and Hes5 expression in PS cDKO mice may be the main
cause underlying the severe depletion of NPCs. However,
substantial levels of Hes1 and Hes5 were still observed in
PS  cDKO mice, suggesting the existence of presenilin-
independent mechanisms for the regulation of Notch sig-
naling [43,44] or Notch-independent regulation of Hes1
expression [45,46].
Notch signaling is important for the regulation of sym-
metric versus asymmetric cell division of neural stem cells
[47,48]. The precise control of this symmetric/asymmetric
cell division is essential not only for the nervous system to
reach its mature size but also for its proper composition
[10,49-51]. Recent reports have shown that two negative
modulators of Notch signaling, Numb and Numblike, are
important for the maintenance of neural progenitor cells
in both earlier stages [52] and later stages [53,54] of neu-
rogenesis in mouse forebrain development. The function
of Numb/Numblike in neural progenitor cells is still
unclear, because two very similar studies reported oppo-
site results for NPC maintenance; one found more NPCs
[53], whereas the other found fewer NPCs [54]. The con-
clusion of our current study that PS and perhaps Notch
signal is required for NPCs to remain in the cell cycle is
consistent with the result of the report by Li et al. [53].
Because the numb/numblike  mutant mice also showed
depletion of neural progenitor cells at early stages of neu-
rogenesis [52], it is not yet clear regarding the function of
Numb/Numblike in the maintenance of NPC population.
Further detailed study is warranted to clarify the func-
tional relation of these molecules in NPC maintenance.
Presenilins in brain hemorrhages
One of the surprising phenotypes of PS cDKO mice is the
severe hemorrhage in the entire brain. In PS  cDKO
embryos, hemorrhages are first seen at E14.5 in small
numbers of the embryos and by E15.5 spread to the entire
brain in all embryos. Nakajima et al. [55] suggested a new
function of PS1 in the endothelial cell of blood vessels
based on the study using PS1  null mice. In the NPC-
restricted PS cDKO mice, PS1 is apparently not eliminated
in the mesoderm-derived blood vessel endothelial cellsMolecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
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[26,56]. Furthermore, cerebral hemorrhages were not
found in NPC-restricted PS1 cKO embryonic brains [53].
These findings argue against the cause of the hemorrhage
in PS cDKO being the possible leakage of the Nestin-Cre
transgene expression in endothelial cells. The generation
of all cell types in the cortex occurs in temporally distinct,
albeit overlapping, phases – neurons are generated first
(peaking at E14 and finishing perinatally), followed by
astrocytes (starting at E13, peaking at P1, finishing by
P10), and then oligodendrocytes (starting at E17 and con-
tinuing until adulthood) [57,58]. Owing to the severe and
almost complete depletion of neural progenitor cells
between E12.5 and E15.5, the PS cDKO brain may not
generate enough astrocytes. Because astrocytes regulate
formation of the blood-brain barrier through direct inter-
action with endothelial cells or by secreting the growth
factors, the absence of astrocytes may result in defects in
the formation of the blood-brain barrier [59-62]. The
related mutant mice (numb/numblike cDKO and PS1 cKO)
that harbor later and milder depletion of neural progeni-
tor cells have not shown cerebral hemorrhages. This sug-
gests that the early depletion of the neural progenitor cells
followed by the loss of astrocytes may be the cause of the
hemorrhage in the PS cDKO brain.
Methods
Mice
The generation of neural specific PS1 cKO mice using Nes-
tin-Cre  transgenic and floxed PS1  mice [63,64] was
described previously [26]. NPC-PS cDKO mice were gen-
erated by crossing the NPC-PS1 cKO mice to the PS2-/-
background. Specifically, NPC-PS cDKO (fPS1∆/fPS1;Nes-
tin-Cre;PS2-/-, fPS1∆ represents a germ-line deletion of the
floxed PS1 locus) mice used in the study were generated
by crossing male fPS1∆/+;Nestin-Cre;PS2-/-  mice with
female  fPS1/fPS1;PS2-/-. Since the floxed PS1  locus is
linked to the Nestin-Cre transgene on the same chromo-
some, we were able to obtain NPC-PS  cDKO (fPS1∆/
fPS1;Nestin-Cre;PS2-/-) and littermate control (fPS1/+;
PS2-/-) embryos at equal ratio. Animal breeding and
experiment protocols were in accordance with the
National Institute of Health Guidelines for use of live ani-
mals and approved by the Harvard Medical Area (HMA)
Standing Committee of Animals.
Preparation of embryos and brain sections
After embryos were fixed in 4% paraformaldehyde at 4°C
for 1.5 h (E11.5) or 2 h (E12.5 and later stages), they were
cryoprotected and embedded in OCT (Sakura Fine Tech-
nical) for frozen sections or dehydrated and embedded in
paraffin for paraffin sections. For the S-phase labeling, the
pregnant mice were injected intraperitoneally with BrdU/
PBS (70 mg/kg body weight; Sigma) 30 min before the
dissection. For the cell cycle exit experiments, BrdU was
injected into the pregnant mice 24 h before the dissection.
Immunostaining and in situ hybridization
For immunostainings, sections were blocked with a block-
ing solution containing 1% BSA, 3% goat serum, and
0.1% Triton X-100 for 3 h at room temperature and incu-
bated with the desired primary antibodies overnight at
room temperature. The following primary antisera or anti-
bodies were used: anti-TUJ-1 antibody (1:400, Babco),
anti-phospho histone 3 (1:100, Santa Cruz Biotechnol-
ogy). For immunohistochemistry, the secondary antibody
labeled with biotin (1:400, Vector Labs) was incubated,
and the ABC complex (Vector Labs) incubation followed.
The staining was performed using the DAPI kit (Vector
Labs) or AP Purple (Roche). For the fluorescence staining
of the tissues, the primary antibody-treated sections were
incubated with the appropriate Alexi Fluor 488- or Alexi
Fluor 594-conjugated secondary antibodies (1:300,
Molecular Probes) for 2 h at room temperature. Images
were viewed on a Zeiss confocal laser scanning micro-
scope and analyzed by using LSM 510 software. In situ
hybridization of brain sections was performed as
described previously [22] using the digoxygenin-labeled
riboprobes. The Hes1,  Hes5, and Dll1  riboprobes were
described previously [22]. All statistical analyses of the
counted cells were performed using Microsoft Excel soft-
ware.
Interkinetic nuclear migration and cell cycle reentering 
assay
For S-Phase nuclei staining, the BrdU injected pregnant
mice were dissected and the embryos were harvested at
E13.5 or E14.5. The frozen sections were stained with an
anti-BrdU antibody for S-Phase labeling. The pictures of
stained slides were taken and the VZ were divided into 11
bins. The S-phase nuclei in each bin with a width of 500
µm were counted, and the numbers of the nuclei and their
positions were shown in the diagram. The M-phase nuclei,
which were stained with an anti-phospho-histone 3 anti-
body, were counted in dorsolateral corte x sections with a
width of 750 µm. The portion of cells that re-enter cell
cycle were calculated as following: The number of cells
labeled with both BrdU and Ki67 (yellow, re-entered cell
cycle) was divided by the total number of BrdU stained
cells (green, BrdU+/Ki67- and yellow, BrdU+/Ki67+) 24 h
after BrdU pulse labeling.
Cell cycle parameters calculation
Analysis of cell cycle kinetics in the cortex using cumula-
tive BrdU-labeling procedures were performed as
described previously [5] with slight modification. Briefly,
BrdU pulses (70 mg/kg body weight) were given to preg-
nant dams every 2 h for up to 8 h. Under these conditions,
all nuclei passing through the S-phase will be labeled.
Dams at the age of E13.5 were sacrificed 0.5, 1.5, 2.5, 4.5
and 8.5 h after the first injection. The embryos were fixed
for 2 h in 4% paraformaldehyde, paraffin-embedded andMolecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
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processed to reveal BrdU immunoreactivity. The propor-
tions of cells in the proliferative zone that were BrdU
labeled were counted in 400 µm wide strips throughout
the telencephalon.
Labeling index (LI; labeled cells as a proportion of total
cells) was calculated for the ventricular zone after the sec-
tions were stained with an anti BrdU antibody. After the
staining, the labeling index at each time point was calcu-
lated as the number of BrdU-positive nuclei divided by
the total nuclei count in the ventricular zone. The result-
ing data were then used to determine the time of BrdU
labeling needed to reach the maximum value of BrdU-
stained nuclei, which corresponds to the total cell cycle
length subtracted by the length of S phase (Tc-Ts).
Quantitative real-time RT-PCR
At E13.5, cortexes were collected for the preparation of
total RNA using Tri reagent (Sigma). The cDNA was syn-
thesized using the Superscript II first-strand cDNA synthe-
sis system (Gibco BRL). Oligonucleotide primers were
designed using Primer Express software 1.0 (Applied Bio-
systems). The specificity of primers was determined by gel
electrophoresis of PCR products to ensure a single band
with predicted size. Quantitative PCR reaction was per-
formed using SYBR Green on an ABI PRISM 7700
Sequence Detection System (Applied Biosystems). Rela-
tive quantification of gene expression was performed
using the comparative CT method according to manufac-
turer's recommended protocol (User Bulletin #2, ABI
PRISM 7700 Sequence Detection System, Perkin-Elmer).
Levels of target mRNA were normalized using 18S rRNA.
The change of the expression of a target gene in the PS
cDKO embryonic brain relative to the littermate control
was calculated as: Fold change = 2-(∆CT, Tg-∆CT, control).
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
WYK planned and performed the experiments and wrote
the paper, JS supervised the project and wrote the paper.
All authors have read and approved the final manuscript.
Acknowledgements
The authors thank Drs. Beglopoulos and Wines-Samuelson and other 
members of the Shen laboratory for invaluable help and discussions.
References
1. Sidman RL, Miale IL, Feder N: Cell proliferation and migration in
the primitive ependymal zone: an autoradiographic study of
histogenesis in the nervous system.  Exp Neurol 1959, 1:322-333.
2. Altman SABJ: Neocortical Development.  New York , Raven
Press; 1991. 
3. Takahashi T, Goto T, Miyama S, Nowakowski RS, Caviness VS Jr.:
Sequence of neuron origin and neocortical laminar fate: rela-
tion to cell cycle of origin in the developing murine cerebral
wall.  J Neurosci 1999, 19(23):10357-10371.
4. Takahashi T, Nowakowski RS, Caviness VS Jr.: Early ontogeny of
the secondary proliferative population of the embryonic
murine cerebral wall.  J Neurosci 1995, 15(9):6058-6068.
5. Takahashi T, Nowakowski RS, Caviness VS Jr.: Cell cycle parame-
ters and patterns of nuclear movement in the neocortical
proliferative zone of the fetal mouse.  J Neurosci 1993,
13(2):820-833.
6. Temple S: The development of neural stem cells.  Nature 2001,
414(6859):112-117.
7. Anderson DJ: Stem cells and pattern formation in the nervous
system: the possible versus the actual.  Neuron 2001,
30(1):19-35.
8. Qian X, Davis AA, Goderie SK, Temple S: FGF2 concentration
regulates the generation of neurons and glia from multipo-
tent cortical stem cells.  Neuron 1997, 18(1):81-93.
9. Qian X, Shen Q, Goderie SK, He W, Capela A, Davis AA, Temple S:
Timing of CNS cell generation: a programmed sequence of
neuron and glial cell production from isolated murine corti-
cal stem cells.  Neuron 2000, 28(1):69-80.
10. Shen Q, Zhong W, Jan YN, Temple S: Asymmetric Numb distri-
bution is critical for asymmetric cell division of mouse cere-
bral cortical stem cells and neuroblasts.  Development 2002,
129(20):4843-4853.
11. Hitoshi S, Alexson T, Tropepe V, Donoviel D, Elia AJ, Nye JS, Conlon
RA, Mak TW, Bernstein A, van der Kooy D: Notch pathway mol-
ecules are essential for the maintenance, but not the gener-
ation, of mammalian neural stem cells.  Genes Dev 2002,
16(7):846-858.
12. Lutolf S, Radtke F, Aguet M, Suter U, Taylor V: Notch1 is required
for neuronal and glial differentiation in the cerebellum.
Development 2002, 129(2):373-385.
13. de la Pompa JL, Wakeham A, Correia KM, Samper E, Brown S, Aguil-
era RJ, Nakano T, Honjo T, Mak TW, Rossant J, Conlon RA: Conser-
vation of the Notch signalling pathway in mammalian
neurogenesis.  Development 1997, 124(6):1139-1148.
14. Takahashi T, Nowakowski RS, Caviness VS Jr.: Interkinetic and
migratory behavior of a cohort of neocortical neurons aris-
ing in the early embryonic murine cerebral wall.  J Neurosci
1996, 16(18):5762-5776.
15. Caric D, Gooday D, Hill RE, McConnell SK, Price DJ: Determina-
tion of the migratory capacity of embryonic cortical cells
lacking the transcription factor Pax-6.  Development 1997,
124(24):5087-5096.
16. Hutton M, Hardy J: The presenilins and Alzheimer's disease.
Hum Mol Genet 1997, 6:1639-1646.
17. Wines-Samuelson M, Shen J: Presenilins in the developing, adult,
and aging cerebral cortex.  Neuroscientist 2005, 11(5):441-451.
18. Yoon K, Gaiano N: Notch signaling in the mammalian central
nervous system: insights from mouse mutants.  Nat Neurosci
2005, 8(6):709-715.
19. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate
control and signal integration in development.  Science 1999,
284(5415):770-776.
20. Justice NJ, Jan YN: Variations on the Notch pathway in neural
development.  Curr Opin Neurobiol 2002, 12:64-70.
21. Schuurmans C, Guillemot F: Molecular mechanisms underlying
cell fate specification in the developing telencephalon.  Curr
Opin Neurobiol 2002, 12(1):26-34.
22. Handler M, Yang X, Shen J: Presenilin-1 regulates neuronal dif-
ferentiation during neurogenesis.  Development 2000,
127:2593-2606.
23. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S: Skel-
etal and CNS defects in presnilin-1 deficient mice.  Cell 1997,
89:629-639.
24. Steiner H, Duff K, Capell A, Romig H, Grim MG, Lincoln S, Hardy J,
Yu X, Picciano M, Fechteler K, Citron M, Kopan R, Pesold B, Keck S,
Baader M, Tomita T, Iwatsubo T, Baumeister R, Haass C: A loss of
function mutation of presenilin-2 interferes with amyloid ß-
peptide production and Notch signaling.  J Biol Chem 1999,
274:28669-28673.
25. Donoviel DB, Hadjantonakis A, Ikeda M, Zheng H, St George Hyslop
P, Bernstein A: Mice lacking both presenilin genes exhibit early
embryonic patterning defects.  Genes & Dev 1999, 13:2801-2810.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Molecular Neurodegeneration 2008, 3:2 http://www.molecularneurodegeneration.com/content/3/1/2
Page 13 of 13
(page number not for citation purposes)
26. Wines-Samuelson M, Handler M, Shen J: Role of presenilin-1 in
cortical lamination and survival of Cajal-Retzius neurons.
Dev Biol 2005, 277(2):332-346.
27. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankarana-
rayana Rao BS, Chattarji S, Kelleher RJ 3rd, Kandel ER, Duff K, Kirk-
wood A, Shen J: Loss of presenilin function causes impairments
of memory and synaptic plasticity followed by age-depend-
ent neurodegeneration.  Neuron 2004, 42(1):23-36.
28. Hayes NL, Nowakowski RS: Exploiting the dynamics of S-phase
tracers in developing brain: interkinetic nuclear migration
for cells entering versus leaving the S-phase.  Developmental
neuroscience 2000, 22(1-2):44-55.
29. Nowakowski RS, Lewin SB, Miller MW: Bromodeoxyuridine
immunohistochemical determination of the lengths of the
cell cycle and the DNA-synthetic phase for an anatomically
defined population.  J Neurocytol 1989, 18(3):311-318.
30. Yuasa S, Nakajima M, Aizawa H, Sahara N, Koizumi K, Sakai T, Usami
M, Kobayashi S, Kuroyanagi H, Mori H, Koseki H, Shirasawa T:
Impaired cell cycle control of neuronal precursor cells in the
neocortical primordium of presenilin-1-deficient mice.  J Neu-
rosci Res 2002, 70(3):501-513.
31. Takahashi T, Nowakowski RS, Caviness VS Jr.: The cell cycle of the
pseudostratified ventricular epithelium of the embryonic
murine cerebral wall.  J Neurosci 1995, 15(9):6046-6057.
32. Sauer FC: Mitosis in the neural tube.  1935, 62(2):377-405.
33. Soriano S, Kang DE, Fu M, Pestell R, Chevallier N, Zheng H, Koo EH:
Presenilin 1 negatively regulates beta-catenin/T cell factor/
lymphoid enhancer factor-1 signaling independently of beta-
amyloid precursor protein and notch processing.  J Cell Biol
2001, 152(4):785-794.
34. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, Zheng H,
Koo EH: Presenilin couples the paired phosphorylation of
beta-catenin independent of axin: implications for beta-cat-
enin activation in tumorigenesis.  Cell 2002, 110(6):751-762.
35. Chenn A, Walsh CA: Regulation of cerebral cortical size by
control of cell cycle exit in neural precursors.  Science 2002,
297(5580):365-369.
36. Parks AL, Curtis D: Presenilin diversifies its portfolio.  Trends
Genet 2007, 23(3):140-150.
37. Yang X, Klein R, Tian X, Cheng HT, Kopan R, Shen J: Notch activa-
tion induces apoptosis in neural progenitor cells through a
p53-dependent pathway.  Dev Biol 2004, 269(1):81-94.
38. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin
R, Poser SW, Rueger MA, Bae SK, Kittappa R, McKay RD: Notch sig-
nalling regulates stem cell numbers in vitro and in vivo.
Nature 2006, 442(7104):823-826.
39. Ishibashi M, Ang SL, Shiota K, Nakanishi S, Kageyama R, Guillemot F:
Targeted disruption of mammalian hairy and Enhancer of
split homolog-1 (HES-1) leads to up-regulation of neural
helix-loop-helix factors, premature neurogenesis, and severe
neural tube defects.  Genes Dev 1995, 9(24):3136-3148.
40. Kageyama R, Ohtsuka T: The Notch-Hes pathway in mamma-
lian neural development.  Cell Res 1999, 9(3):179-188.
41. Murata K, Hattori M, Hirai N, Shinozuka Y, Hirata H, Kageyama R,
Sakai T, Minato N: Hes1 directly controls cell proliferation
through the transcriptional repression of p27Kip1.  Mol Cell
Biol 2005, 25(10):4262-4271.
42. Ohtsuka T, Sakamoto M, Guillemot F, Kageyama R: Roles of the
basic helix-loop-helix genes Hes1 and Hes5 in expansion of
neural stem cells of the developing brain.  J Biol Chem 2001,
276(32):30467-30474.
43. Berechid BE, Kitzmann M, Foltz DR, Roach AH, Seiffert D, Thompson
LA, Olson RE, Bernstein A, Donoviel DB, Nye JS: Identification and
characterization of presenilin-independent Notch signaling.
J Biol Chem 2002, 277(10):8154-8165.
44. Huppert SS, Ilagan MX, De Strooper B, Kopan R: Analysis of notch
function in presomitic mesoderm suggests a gamma-secre-
tase-independent role for presenilins in somite differentia-
tion.  Dev Cell 2005, 8(5):677-688.
45. Feder JN, Jan LY, Jan YN: A rat gene with sequence homology
to the Drosophila gene hairy is rapidly induced by growth
factors known to influence neuronal differentiation.  Mol Cell
Biol 1993, 13(1):105-113.
46. Solecki DJ, Liu XL, Tomoda T, Fang Y, Hatten ME: Activated
Notch2 signaling inhibits differentiation of cerebellar gran-
ule neuron precursors by maintaining proliferation.  Neuron
2001, 31(4):557-568.
47. Roegiers F, Younger-Shepherd S, Jan LY, Jan YN: Two types of
asymmetric divisions in the Drosophila sensory organ pre-
cursor cell lineage.  Nat Cell Biol 2001, 3(1):58-67.
48. Ceron J, Gonzalez C, Tejedor FJ: Patterns of cell division and
expression of asymmetric cell fate determinants in postem-
bryonic neuroblast lineages of Drosophila.  Dev Biol 2001,
230(2):125-138.
49. Sommer L, Rao M: Neural stem cells and regulation of cell
number.  Prog Neurobiol 2002, 66(1):1-18.
50. Wodarz A, Huttner WB: Asymmetric cell division during neu-
rogenesis in Drosophila and vertebrates.  Mech Dev 2003,
120(11):1297-1309.
51. Matsuzaki F: Asymmetric division of Drosophila neural stem
cells: a basis for neural diversity.  Curr Opin Neurobiol 2000,
10(1):38-44.
52. Petersen PH, Zou K, Hwang JK, Jan YN, Zhong W: Progenitor cell
maintenance requires numb and numblike during mouse
neurogenesis.  Nature 2002, 419(6910):929-934.
53. Li HS, Wang D, Shen Q, Schonemann MD, Gorski JA, Jones KR, Tem-
ple S, Jan LY, Jan YN: Inactivation of Numb and Numblike in
embryonic dorsal forebrain impairs neurogenesis and dis-
rupts cortical morphogenesis.  Neuron 2003, 40(6):1105-1118.
54. Petersen PH, Zou K, Krauss S, Zhong W: Continuing role for
mouse Numb and Numbl in maintaining progenitor cells
during cortical neurogenesis.  Nat Neurosci 2004, 7(8):803-811.
55. Nakajima M, Yuasa S, Ueno M, Takakura N, Koseki H, Shirasawa T:
Abnormal blood vessel development in mice lacking prese-
nilin-1.  Mech Dev 2003, 120(6):657-667.
56. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock
R, Klein R, Schutz G: Disruption of the glucocorticoid receptor
gene in the nervous system results in reduced anxiety.  Nat
Genet 1999, 23(1):99-103.
57. Sauvageot CM, Stiles CD: Molecular mechanisms controlling
cortical gliogenesis.  Curr Opin Neurobiol 2002, 12(3):244-249.
58. Bayer SA, Altman J: Development of the endopiriform nucleus
and the claustrum in the rat brain.  Neuroscience 1991,
45(2):391-412.
59. Engelhardt B, Conley FK, Kilshaw PJ, Butcher EC: Lymphocytes
infiltrating the CNS during inflammation display a distinctive
phenotype and bind to VCAM-1 but not to MAdCAM-1.  Int
Immunol 1995, 7(3):481-491.
60. Janzer RC, Raff MC: Astrocytes induce blood-brain barrier
properties in endothelial cells.  Nature 1987,
325(6101):253-257.
61. Rieckmann P, Engelhardt B: Building up the blood-brain barrier.
Nat Med 2003, 9(7):828-829.
62. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim
KW: SSeCKS regulates angiogenesis and tight junction for-
mation in blood-brain barrier.  Nat Med 2003, 9(7):900-906.
63. Yu H, Kessler J, Shen J: Heterogeneous populations of ES cells
in the generation of a floxed Presenilin-1 allele.  Genesis 2000,
26(1):5-8.
64. Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi
T, Younkin L, Fedeles B, Wilson MA, Younkin S, Kandel ER, Kirkwood
A, Shen J: APP processing and synaptic plasticity in presenilin-
1 conditional knockout mice.  Neuron 2001, 31(5):713-726.